Skin Patch Medicine Market Report – Research, Industry Analysis Reports and Market Demands

Global Skin Patch Medicine Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report

Buy now

Table of Content

1 Market Overview

1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
- 1.3.1 Overview: Global Skin Patch Medicine Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Methyl Salicylate Patches
- 1.3.3 Rivastigmine Transdermal Patches
- 1.3.4 Fentanyl Transdermal Patches
- 1.3.5 Lidocaine Patches
- 1.3.6 Diclofenac Patches
- 1.3.7 Nicotine Transdermal Patches
- 1.3.8 Other
1.4 Market Analysis by Application
- 1.4.1 Overview: Global Skin Patch Medicine Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.4.2 Pain Management
- 1.4.3 Hormone Therapy
- 1.4.4 Cardiovascular Conditions
- 1.4.5 Neurological and Psychiatric Disorders
- 1.4.6 Others
1.5 Global Skin Patch Medicine Market Size & Forecast
- 1.5.1 Global Skin Patch Medicine Consumption Value (2021 & 2025 & 2032)
- 1.5.2 Global Skin Patch Medicine Sales Quantity (2021-2032)
- 1.5.3 Global Skin Patch Medicine Average Price (2021-2032)

2 Manufacturers Profiles

3 Competitive Environment: Skin Patch Medicine by Manufacturer

3.1 Global Skin Patch Medicine Sales Quantity by Manufacturer (2021-2026)
3.2 Global Skin Patch Medicine Revenue by Manufacturer (2021-2026)
3.3 Global Skin Patch Medicine Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of Skin Patch Medicine by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 Skin Patch Medicine Manufacturer Market Share in 2025
- 3.4.3 Top 6 Skin Patch Medicine Manufacturer Market Share in 2025
3.5 Skin Patch Medicine Market: Overall Company Footprint Analysis
- 3.5.1 Skin Patch Medicine Market: Region Footprint
- 3.5.2 Skin Patch Medicine Market: Company Product Type Footprint
- 3.5.3 Skin Patch Medicine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

4.1 Global Skin Patch Medicine Market Size by Region
- 4.1.1 Global Skin Patch Medicine Sales Quantity by Region (2021-2032)
- 4.1.2 Global Skin Patch Medicine Consumption Value by Region (2021-2032)
- 4.1.3 Global Skin Patch Medicine Average Price by Region (2021-2032)
4.2 North America Skin Patch Medicine Consumption Value (2021-2032)
4.3 Europe Skin Patch Medicine Consumption Value (2021-2032)
4.4 Asia-Pacific Skin Patch Medicine Consumption Value (2021-2032)
4.5 South America Skin Patch Medicine Consumption Value (2021-2032)
4.6 Middle East & Africa Skin Patch Medicine Consumption Value (2021-2032)

5 Market Segment by Type

5.1 Global Skin Patch Medicine Sales Quantity by Type (2021-2032)
5.2 Global Skin Patch Medicine Consumption Value by Type (2021-2032)
5.3 Global Skin Patch Medicine Average Price by Type (2021-2032)

6 Market Segment by Application

6.1 Global Skin Patch Medicine Sales Quantity by Application (2021-2032)
6.2 Global Skin Patch Medicine Consumption Value by Application (2021-2032)
6.3 Global Skin Patch Medicine Average Price by Application (2021-2032)

7 North America

7.1 North America Skin Patch Medicine Sales Quantity by Type (2021-2032)
7.2 North America Skin Patch Medicine Sales Quantity by Application (2021-2032)
7.3 North America Skin Patch Medicine Market Size by Country
- 7.3.1 North America Skin Patch Medicine Sales Quantity by Country (2021-2032)
- 7.3.2 North America Skin Patch Medicine Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

8.1 Europe Skin Patch Medicine Sales Quantity by Type (2021-2032)
8.2 Europe Skin Patch Medicine Sales Quantity by Application (2021-2032)
8.3 Europe Skin Patch Medicine Market Size by Country
- 8.3.1 Europe Skin Patch Medicine Sales Quantity by Country (2021-2032)
- 8.3.2 Europe Skin Patch Medicine Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

9.1 Asia-Pacific Skin Patch Medicine Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific Skin Patch Medicine Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific Skin Patch Medicine Market Size by Region
- 9.3.1 Asia-Pacific Skin Patch Medicine Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific Skin Patch Medicine Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

10.1 South America Skin Patch Medicine Sales Quantity by Type (2021-2032)
10.2 South America Skin Patch Medicine Sales Quantity by Application (2021-2032)
10.3 South America Skin Patch Medicine Market Size by Country
- 10.3.1 South America Skin Patch Medicine Sales Quantity by Country (2021-2032)
- 10.3.2 South America Skin Patch Medicine Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

11.1 Middle East & Africa Skin Patch Medicine Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa Skin Patch Medicine Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa Skin Patch Medicine Market Size by Country
- 11.3.1 Middle East & Africa Skin Patch Medicine Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa Skin Patch Medicine Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

12.1 Skin Patch Medicine Market Drivers
12.2 Skin Patch Medicine Market Restraints
12.3 Skin Patch Medicine Trends Analysis
12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

13.1 Raw Material of Skin Patch Medicine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Skin Patch Medicine
13.3 Skin Patch Medicine Production Process
13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
14.2 Skin Patch Medicine Typical Distributors
14.3 Skin Patch Medicine Typical Customers

15 Research Findings and Conclusion

16 Appendix

16.1 Methodology
16.2 Research Process and Data Source

Description

According to our (Global Info Research) latest study, the global Skin Patch Medicine market size was valued at US$ 140 million in 2025 and is forecast to a readjusted size of US$ 195 million by 2032 with a CAGR of 5.0% during review period.
Skin Patch Medicine refers to a type of transdermal drug delivery system (TDDS) where medication is incorporated into a patch that adheres to the skin and gradually delivers active ingredients into the bloodstream through the skin barrier. In 2024, global Skin Patch Medicine production reached approximately 21643 K units, with an average global market price of around US$ 6 per unit.
The Skin Patch Medicine market refers to the segment of transdermal drug delivery systems that administer active pharmaceutical ingredients through patches applied directly to the skin, offering controlled and sustained release into the bloodstream. This market is driven by the advantages of non-invasive drug administration, improved patient compliance, reduced gastrointestinal side effects, and the ability to bypass first-pass metabolism compared with oral dosage forms. Skin patch medicines are used across a wide range of therapeutic areas, including pain management, hormone replacement therapy, smoking cessation, cardiovascular disorders, and neurological conditions. Growth in this market is supported by technological innovations in patch materials, adhesives, and drug formulations, as well as increasing demand for self-administered treatments, though it also faces challenges such as skin irritation, limited drug types suitable for transdermal delivery, and high manufacturing costs.
This report is a detailed and comprehensive analysis for global Skin Patch Medicine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Skin Patch Medicine market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Skin Patch Medicine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Skin Patch Medicine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Skin Patch Medicine market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Skin Patch Medicine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Skin Patch Medicine market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Johnson & Johnson, Viatris, Hisamatsu Pharmaceuticals, Boehringer Ingelheim, Endo, Teva Pharmaceutical, Agile Therapeutics, Bayer, Nitto Denko, Iontopatch, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Skin Patch Medicine market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Methyl Salicylate Patches
Rivastigmine Transdermal Patches
Fentanyl Transdermal Patches
Lidocaine Patches
Diclofenac Patches
Nicotine Transdermal Patches
Other
Market segment by Application
Pain Management
Hormone Therapy
Cardiovascular Conditions
Neurological and Psychiatric Disorders
Others
Major players covered
Johnson & Johnson
Viatris
Hisamatsu Pharmaceuticals
Boehringer Ingelheim
Endo
Teva Pharmaceutical
Agile Therapeutics
Bayer
Nitto Denko
Iontopatch
Medherant
AdhexPharma
Evernow
Alvogen Group
Sparsha Pharma
Luye Pharma Group
Novartis AG
Purdue Pharma
Mundipharma
Amneal
Hikma
AbbVie
UCB Pharma
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Skin Patch Medicine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Skin Patch Medicine, with price, sales quantity, revenue, and global market share of Skin Patch Medicine from 2021 to 2026.
Chapter 3, the Skin Patch Medicine competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Skin Patch Medicine breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Skin Patch Medicine market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Skin Patch Medicine.
Chapter 14 and 15, to describe Skin Patch Medicine sales channel, distributors, customers, research findings and conclusion.

Buy now